194 related articles for article (PubMed ID: 24056014)
1. Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi.
Fairlie-Clarke KJ; Allen JE; Read AF; Graham AL
Infect Genet Evol; 2013 Dec; 20():270-5. PubMed ID: 24056014
[TBL] [Abstract][Full Text] [Related]
2. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM; Flaherty PR; Romero MM; Weidanz WP
Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
[TBL] [Abstract][Full Text] [Related]
3. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
4. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
[TBL] [Abstract][Full Text] [Related]
5. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
Cheesman S; Tanabe K; Sawai H; O'Mahony E; Carter R
Infect Genet Evol; 2009 Mar; 9(2):248-55. PubMed ID: 19121414
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
[TBL] [Abstract][Full Text] [Related]
7. Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi.
Achtman AH; Stephens R; Cadman ET; Harrison V; Langhorne J
Parasite Immunol; 2007 Sep; 29(9):435-44. PubMed ID: 17727567
[TBL] [Abstract][Full Text] [Related]
8. Mixed allele malaria vaccines: host protection and within-host selection.
Barclay VC; Chan BH; Anders RF; Read AF
Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
[TBL] [Abstract][Full Text] [Related]
9. Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.
Fairlie-Clarke KJ; Lamb TJ; Langhorne J; Graham AL; Allen JE
BMC Immunol; 2010 Feb; 11():6. PubMed ID: 20163714
[TBL] [Abstract][Full Text] [Related]
10. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.
Barclay VC; Sim D; Chan BH; Nell LA; Rabaa MA; Bell AS; Anders RF; Read AF
PLoS Biol; 2012; 10(7):e1001368. PubMed ID: 22870063
[TBL] [Abstract][Full Text] [Related]
11. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide sequence analysis and epitope mapping of the merozoite surface protein 1 from Plasmodium chabaudi chabaudi AS.
McKean PG; O'Dea K; Brown KN
Mol Biochem Parasitol; 1993 Dec; 62(2):199-209. PubMed ID: 7511214
[TBL] [Abstract][Full Text] [Related]
13. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
14. A single gene copy merozoite surface antigen and immune evasion?
O'Dea KP; McKean PG; Jarra W; Brown KN
Parasite Immunol; 1996 Apr; 18(4):165-72. PubMed ID: 9223171
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
[TBL] [Abstract][Full Text] [Related]
16. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.
Anders RF; Crewther PE; Edwards S; Margetts M; Matthew ML; Pollock B; Pye D
Vaccine; 1998; 16(2-3):240-7. PubMed ID: 9607037
[TBL] [Abstract][Full Text] [Related]
17. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria.
Pattaradilokrat S; Cheesman SJ; Carter R
PLoS One; 2007 Sep; 2(9):e857. PubMed ID: 17848988
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antigen-specific antibodies and their isotypes in experimental malaria.
van der Heyde HC; Burns JM; Weidanz WP; Horn J; Gramaglia I; Nolan JP
Cytometry A; 2007 Apr; 71(4):242-50. PubMed ID: 17252581
[TBL] [Abstract][Full Text] [Related]
19. Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides.
Salvatore D; Hodder AN; Zeng W; Brown LE; Anders RF; Jackson DC
Vaccine; 2002 Oct; 20(29-30):3477-84. PubMed ID: 12297393
[TBL] [Abstract][Full Text] [Related]
20. Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.
Mota MM; Brown KN; Do Rosário VE; Holder AA; Jarra W
Infect Immun; 2001 Apr; 69(4):2535-41. PubMed ID: 11254617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
